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Abstract
Background: The vesicular GABA transporter (VGAT) loads GABA and glycine from the neuronal cytoplasm into
synaptic vesicles. To address functional importance of VGAT during embryonic development, we generated global
VGAT knockout mice and analyzed them.
Results: VGAT knockouts at embryonic day (E) 18.5 exhibited substantial increases in overall GABA and glycine, but
not glutamate, contents in the forebrain. Electrophysiological recordings from E17.5-18.5 spinal cord motoneurons
demonstrated that VGAT knockouts presented no spontaneous inhibitory postsynaptic currents mediated by GABA
and glycine. Histological examination of E18.5 knockout fetuses revealed reductions in the trapezius muscle,
hepatic congestion and little alveolar spaces in the lung, indicating that the development of skeletal muscle, liver
and lung in these mice was severely affected.
Conclusion: VGAT is fundamental for the GABA- and/or glycine-mediated transmission that supports embryonic
development. VGAT knockout mice will be useful for further investigating the roles of VGAT in normal physiology
and pathophysiologic processes.
Background
GABAergic and glycinergic neurotransmissions play cri-
tical roles in the central nervous system (CNS), because
they regulate network activity and are essential for a
number of brain functions, such as cognition, percep-
tion, movement and respiration. In the adult mamma-
lian CNS, GABA and glycine are the main inhibitory
neurotransmitters, but in fetal life and early postnatal
development, both neurotransmitters act as either exci-
tatory or inhibitory, depending on the intracellular
chloride concentration.
GABA is synthesized from glutamic acid by gluta-
mate decarboxylase (GAD) [1] and is accumulated into
synaptic vesicles by the vesicular GABA transporter
(VGAT) [2,3]. Two isozymes of GAD, GAD65 and
GAD67, are primarily expressed in GABAergic neurons
[4,5]. GAD65 knockout mice exhibit spontaneous sei-
zures, elevated anxiety and altered sensitivity to pain
[6,7]. GAD67 knockout mice die of cleft palate at birth
[8]. VGAT is present in both GABAergic and glyciner-
gic neurons and is also called the vesicular inhibitory
amino acid transporter (VIAAT) [3,9]. In addition to
its presence at GABAergic and glycinergic synapses,
the role of VGAT/VIAAT in GABA and glycine release
is supported by electrophysiological evidence from pri-
mary cultured hippocampal or spinal cord neurons of
VGAT knockout mice [10] and VGAT-transfected
secretory cells [11]. VGAT knockout mice die perina-
tally and show a hunched posture, cleft palate and
omphalocele [10].
Divergent roles for the VGAT proteins are implicated
in the nervous system. However, the contribution of
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largely unclear. For example, neither muscle, lung nor
liver phenotypes have been reported for these knockout
mice. We independently generated VGAT knockout
mice. To further investigate the roles of VGAT during
development, we performed histopathological analyses
in VGAT knockout muscle, lung and liver at an
embryonic stage. These mice showed a reduction in the
trapezius muscles, smaller saccules in the lung, and con-
gestion in the liver. In addition, in VGAT knockout
spinal cord motoneurons (MNs), spontaneous inhibitory
postsynaptic currents (IPSCs) were absent. These experi-
ments indicate that VGAT has an important role in the
GABA- and/or glycine-mediated transmission that sup-
ports life. Preliminary results have been published in an
abstract form [12].
Results
Generation of VGAT
-/- mice
The targeting strategy used for the generation of VGAT
knockout mice is shown in Figure 1A. Exons 2 and 3
encode the putative ten-transmembrane domain and C-
terminus of the VGAT protein [3,13], and accordingly,
the deletion of these regions was expected to destroy
the function of the VGAT protein. Correctly targeted ES
cell clones isolated were microinjected into blastocysts
to generate chimeric mice. These mice were then
crossed with C57BL/6 mice to generate heterozygous
mice carrying one floxneo allele (VGAT
floxneo/+ mice).
We generated the VGAT knockout allele by crossing
VGAT
floxneo/+ mice with CAG-Cre mice, in which Cre
recombinase is expressed ubiquitously [14]. Genotyping
was performed by Southern blot analysis (Figure 1B)
and PCR (Figure 1C), and the DNA sequences around
the loxP site in the knockout allele were also confirmed
(data not shown). To obtain homozygous VGAT knock-
out (VGAT
-/-) mice, we intercrossed the VGAT
+/- mice.
Western blot analysis revealed no VGAT protein
expression in embryonic day (E) 18.5 VGAT
-/- brain,
whereas VGAT protein expression in VGAT
+/- mouse
brains was reduced to about half of the wild-type level
(Figure 1D). All E18.5 VGAT
-/- fetuses displayed cleft
palate (Figure 1E) and omphalocele (Figure 1F), pheno-
types that are consistent with those described by Wojcik
et al. [10].
No VGAT
-/- mice survived beyond birth (Table 1). To
estimate the time of death of VGAT
-/- mice, we per-
formed timed matings of the VGAT
+/- mice and
obtained the fetuses via cesarean section. Among
the E18.5 offspring derived from the intercrosses of
VGAT
+/- mice, VGAT
-/- fetuses were obtained at the
expected Mendelian ratio (27.3%, 77 VGAT
-/- of 282 lit-
termates) and more than 97% of them (75 of 77) were
alive (judged by their umbilical beats or heartbeats,
Table 1). When delivered by cesarean section on E18.5,
both VGAT
+/+ (7 of 7) and VGAT
+/- (11 of 12) fetuses
began respiration, but none of the VGAT
-/- fetuses (n =
7) began to breathe. Therefore, it is probable that
VGAT
-/- mice died at birth due to respiratory failure.
Elevations in GABA and glycine contents in VGAT
-/-
forebrains
In the absence of vesicular storage, neurotransmitter
levels can be altered, and this alteration depends on the
absence of the vesicular transporter. For example,
monoamines are drastically reduced in vesicular monoa-
mine transporter 2 knockout brains [15], but acetylcho-
line (ACh) is increased in vesicular acetylcholine
transporter (VAChT) knockout brains compared to con-
trol wild-type brains [16]. Therefore, we measured the
amount of the neurotransmitters, GABA, glycine and
glutamate in E18.5 VGAT
-/- forebrain by HPLC. As
shown in Figure 2A, VGAT
-/- fetuses showed significant
increases in both GABA and glycine, but not glutamate,
compared to VGAT
+/+ fetuses. It is possible that the
increase in GABA content in VGAT
-/- fetuses was due
to the elevated expression levels of GABA-synthesizing
enzymes. To test for this possibility, we analyzed the
expression levels of GAD65 and GAD67 in the embryo-
nic brains. Our Western blot analysis showed that
the expression levels of both GAD65 and GAD67 in
VGAT
+/+ and VGAT
-/- brains were similar (Figure 2B).
These results indicate that the increase in GABA con-
tent was not derived from elevated amounts of GABA-
synthesizing enzymes in VGAT
-/- embryos.
Absence of functional inhibitory synaptic transmission in
the VGAT
-/- spinal cord
To examine the physiological nature of synaptic inputs
to spinal MNs, we performed whole-cell patch-clamp
recordings using isolated spinal cord preparations taken
from VGAT
-/- and control mouse embryos. In these
preparations, the neuronal connections within the spinal
cord are kept relatively intact [17]. In control lumbar
MNs, spontaneous outward currents were observed
when the membrane potential was depolarized at
-40 mV above the chloride ion reversal potential
(approximately -78 mV in the present experimental con-
dition). These currents were blocked by bath application
of the glycinergic antagonist strychnine and the
GABAergic antagonist picrotoxin, indicating that the
currents were IPSCs (n = 8, Figure 3A). In contrast, we
did not detect such spontaneous IPSCs in VGAT
-/-
MNs (n = 12, Figure 3B). When the membrane potential
was held at -70 mV, spontaneous inward currents were
observed both in control and VGAT
-/- MNs (Figure 3A
and 3B). These inward currents were abolished by
the concomitant bath application of the ionotropic
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Figure 1 Generation of VGAT
-/- mice. (A) Schematic representation of the wild-type VGAT allele, the targeting vector, the VGAT-floxneo allele,
and the VGAT knockout allele. Exons are represented by numbered white boxes. LoxP sites (open diamonds) and a PGK-Neo cassette (neo; gray
box) flanked by the frt sites (open ellipses) were introduced into the wild-type VGAT locus by homologous recombination to produce the
floxneo allele. The probes used for Southern blot analysis are indicated as white (5’ probe) and red (3’ probe) boxes. The expected sizes of the
KpnI- and NcoI-digested genomic DNA fragments hybridized with the 5’ and 3’ probes, respectively, are indicated as lines under the schemes.
Relevant restriction sites are indicated as follows: K, KpnI; N, NcoI. PCR primers are indicated as arrows. (B) (Left) Southern blot analysis of KpnI-
digested genomic DNA isolated from VGAT
+/+ (+/+) and VGAT
floxneo/+ (Floxneo/+) mice using the 5’ probe indicated in A. The wild-type allele
corresponds to the 15.2 kb band, whereas the floxneo allele corresponds to the 12.0 kb band. (Right) Southern blot analysis of NcoI-digested
genomic DNA isolated from VGAT
+/+ (+/+), VGAT
+/- (+/-), VGAT
-/- (-/-), and VGAT
floxneo/+ (Floxneo/+) mice using the 3’ probe indicated in A. The
wild-type allele, the knockout allele, and the floxneo allele correspond to the 10.7 kb, 7.4 kb, and 6.3 kb bands, respectively. (C) Genotyping of
offspring from intercrosses of VGAT
+/- mice by PCR. Three primers were used (see Methods). Primers P2 and P3 produce a 183 bp fragment that
represents the wild-type allele, whereas primers P1 and P3 produce a 430 bp fragment that represents the knockout allele. (D) Western blot
analysis of E18.5 whole brain homogenates from VGAT
+/+ (+/+), VGAT
+/- (+/-), VGAT
-/- (-/-) using the anti-VGAT antibody directed against an
N-terminal epitope. (E) Ventral views of the upper jaw of E18.5 VGAT
+/+ (+/+) and VGAT
-/- (-/-) mice. In contrast to the completely fused palate
of a VGAT
+/+ mouse, secondary palatal shelves of a VGAT
-/- mouse did not contact each other (arrows), and its nasal cavity (asterisk) could be
seen. (F) Lateral views of E18.5 VGAT
+/+ (+/+) and VGAT
-/- (-/-) mice. An arrow indicates omphalocele in a VGAT
-/- mouse. In addition, the VGAT
-/-
mouse showed an extremely hunched position in contrast to the VGAT
+/+ mouse.
Saito et al. Molecular Brain 2010, 3:40
http://www.molecularbrain.com/content/3/1/40
Page 3 of 13glutamate receptor blockers, a non-NMDA receptor
antagonist 6-cyano-7-nitroquinoxaline-2,3-dione
(CNQX) and an NMDA receptor antagonist D-2-amino-
5-phosphonovaleric acid (AP5), indicating that MNs
received excitatory synaptic transmission in the VGAT
-/-
spinal cord.
Alterations in body weight, response to stimuli, trapezius
muscle, liver and lung of VGAT
-/- mice
Wojcik et al. [10] reported that VGAT
-/- mice display the
phenotypes such as cleft palate, omphalocele, hunched
posture, immobility and stiffness. However, we proposed
that there would be some other alterations in VGAT
-/-
mice because VGAT is an essential molecule for
GABAergic and glycinergic transmission. To address the
question whether VGAT is essential for fetal growth, we
initially measured the body weight of VGAT
-/- fetuses
compared to VGAT
+/+ and VGAT
+/- littermates. The
body weight of the E18.5 VGAT
-/- fetuses was signifi-
cantly lower than that of VGAT
+/+ and VGAT
+/- fetuses
(VGAT
+/+: 1.18 ± 0.11 grams, n = 17; VGAT
+/-:1 . 2 0±
0.08 grams, n = 45; VGAT
-/-: 1.05 ± 0.11 grams, n = 32
[mean ± SD], P < 0.001, one-way ANOVA, post hoc Fish-
er’s least significant difference test). These results indi-
cate that VGAT is important for fetal growth.
VGAT
-/- fetuses exhibited immobility and lacked spon-
taneous limb and body movements, which are consistent
with a report by Wojcik et al. [10]. To further address the
question of whether the lack of movement in VGAT
-/-
fetuses was restricted to a defect in spontaneous move-
ment, we examined the response of E18.5 VGAT
-/-
fetuses to mechanical stimuli. VGAT
+/+,V G A T
+/- and
VGAT
-/- fetuses were obtained via cesarean section and
maintained alive in phosphate buffered saline. None of
the VGAT
-/- fetuses (n = 16) responded to a pinch of the
tail by forceps, but all VGAT
+/+ (n = 16) and VGAT
+/-
(n = 53) fetuses responded with a twisting of the trunk.
These results suggest that VGAT
-/- fetuses suffer from
severe impairments in motor function.
Because the hunched posture observed in VGAT
-/-
mice (Figure 1F) suggested defects in skeletal muscles or
bones [18,19], we performed a histological examination
of skeletal muscles and bones in the E18.5 embryos. Tra-
pezius muscle was thinner in VGAT
-/- mice than in the
control mice (Figure 4A, B). The VGAT
-/- ribs in
the lower part were depressed, and their position
was retracted toward the inside compared to control
(Figure 4C, D). Furthermore, the spaces between each rib
appeared narrower in VGAT
-/- mice compared to the
control mice (Figure 4C, D). Abdominal organs were
examined histologically in an attempt to identify patholo-
gical findings associated with defects in VGAT
-/- mice.
Not only omphalocele (Figure 1F) but also hepatic
congestion were characteristic of VGAT
-/- embryos
(Figure 4E, F). These results suggest that the crouching
posture caused by an imbalance of the strength between
the dorsal and ventral muscles made the thorax expand
ineffectively, leading to an increase in intra-abdominal
pressure in VGAT
-/- embryos. Although omphalocele
can be caused by a malformation of the ventral body wall
[20], the rectus abdominis muscle showed no apparent
abnormality in VGAT
-/- mice (data not shown).
The VGAT
-/- mice lacked autonomous and joggling-
induced breathing movements, consistent with the
report by Fujii et al. [21]. However, there is still uncer-
tainty regarding the mechanism responsible for the
respiratory failure caused byt h el o s so fV G A Tp r o t e i n .
To understand the pathology causing respiratory failure
in VGAT
-/- mice, we fixed embryos at E18.5, the day
prior to birth, and performed pathohistology of the
lungs. Examination under a microscope revealed that
the VGAT
-/- lung barely contained alveolar spaces com-
pared to the control lung (Figure 4G, H). A possible
cause of atelectasis was reported defect in the dia-
phragm [22]. We examined the VGAT
-/- diaphragm his-
tologically, but we didn’t detect any difference in the
diaphragm between the VGAT
-/- and control mice.
The alterations in the VGAT
-/- muscle, liver and lung
were likely caused by the loss of VGAT in the CNS, but
not the loss of VGAT in the peripheral tissue because
VGAT transcripts were detected in brain and spinal
cord, but not in muscle, liver or lung [2,3].
Comparison of cleft palate and omphalocele between
VGAT
-/- mice and GAD67
-/- mice
Cleft palate is exhibited by VGAT
-/- and GAD67
-/- mice
[8,10,23], demonstrating that GABAergic transmissions
are involved in palatogenesis. Because VGAT and
Table 1 Genotypes of offspring from intercrosses of VGAT
+/- mice and phenotypes of VGAT
-/- mice
Age Genotype Phenotype
+/+ +/- -/- No. of -/- found dead No. of -/- with omphalocele No. of -/- with cleft palate
E18.5 69
(24.5%)
136
(48.2%)
77
(27.3%)
2/77* 77/77* 29/29*
Newborn 22
(19.6%)
76
(67.9%)
14
(12.5%)
14/14* Not determined Not determined
*affected/examined.
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Figure 2 Neurotransmitter contents and expression levels of GAD65 and GAD67. (A) Neurotransmitter contents of E18.5 mouse forebrain.
VGAT
-/- mice showed significantly higher levels of GABA and glycine than VGAT
+/+ mice, but not glutamate. Values represent means ± SD (*P <
0.05; Student’s t-test, n = 5-13 per group). (B) Western blot analysis. The expression level of GAD65 and GAD67 in whole brain homogenates was
not significantly different between VGAT
+/+ (+/+) and VGAT
-/- (-/-) mice. Equal amounts of protein were loaded and probed with an antibody
that recognizes both GAD65 and GAD67. For the statistical comparison, the same blot was probed with anti-b-actin antibody as an internal
control and measurements for GAD65 and GAD67 bands were normalized to the b-actin bands (GAD65: VGAT
+/+ 100 ± 23%; VGAT
-/- 111 ± 20%,
n = 4, P = 0.71) (GAD67: VGAT
+/+ 100 ± 18%; VGAT
-/- 93 ± 17%, n = 4, P = 0.80).
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Page 5 of 13GAD67 exhibit different molecular functions, we investi-
gated whether the severity of cleft palate was different
between VGAT
-/- and GAD67
-/- mice. Figure 5A shows
hematoxylin-eosin staining of coronal sections from the
oral region. In the cleft palate of VGAT
-/- mice, the
palatal shelves remained vertical along the sides of the
tongue (3 of 3). However, in GAD67
-/- mice, the palatal
shelves were elevated up to a horizontal position (3 of
3). In one of the GAD67
-/- mice, the palatal shelves
even fused with each other completely (data not shown).
These observations suggest that palatogenesis progresses
further in GAD67
-/- mice than in VGAT
-/- mice. Our
observations also suggestt h a tc l e f tp a l a t ei nV G A T
-/-
mice is more severe than in GAD67
-/- mice.
The observation of omphalocele in VGAT
-/- mice
prompted us to investigate whether GAD67
-/- mice dis-
played omphalocele. We found omphalocele in GAD67
-/-
and VGAT
-/- mice (Figure 5B), indicating that GABA
signaling is involved in its onset. The incidence rate of
omphalocele in GAD67
-/- mice was 43% (17 of 40),
whereas the incidence in VGAT
-/- mice was 100% (77 of
7 7 ;s e ea l s oT a b l e1 ) .T h u s ,t h ep e n e t r a n c eo fo m p h a l o -
cele in GAD67
-/- mice was lower than in VGAT
-/- mice.
The size of omphalocele appeared to be larger in
VGAT
-/- mice than in GAD67
-/- mice. Taken together,
these data suggest omphalocele in GAD67
-/- mice is less
severe than in VGAT
-/- mice, similar to what was
observed with the cleft palate.
Discussion
The present work addresses the contribution of VGAT
to embryonic development. We generated VGAT mice
and found that VGAT is fundamental for GABA and/or
glycine release in the spinal cord. Moreover, in the
absence of VGAT, there are profound effects on muscle,
liver and lung during embryonic development. These
observations bear important consequences for under-
standing the functional roles of VGAT from the cellular
to the whole-body level.
Generation of VGAT knockout mice
Wojcik et al. [10] generated VGAT knockout mice, in
which a mutation was inserted into exon 1, and these
mice exhibit cleft palate and omphalocele. Here, we gen-
erated floxed VGAT knockout mice, in which exons 2
and 3 of the VGAT gene were flanked by loxP sites.
Crossing the floxed VGAT mice to CAG-Cre mice
reproduced the phenotypes of cleft palate and omphalo-
cele. Exons 1 and 2/3 encode the cytoplasmic domain
and the transmembrane domain, respectively [3,13]. Our
results demonstrate that exons 2 and 3 are dispensable
for the function of VGAT.
VGAT
floxneo/floxneo mice were born at the expected fre-
quency, were viable, did not have a cleft palate or ompha-
locele, and were overtly indistinguishable from their wild-
type littermates. Western blot showed that the level of
VGAT protein expression in VGAT
floxneo/floxneo brain
was not different from the wild-type brain (Additional
file 1: Supplementary Figure S1). These results suggest
that a loxP sequence and an frt-flanked phosphoglycerate
kinase promoter-driven neomycin-resistance gene (PGK-
Neo) inserted into intron 1 and the 3’-flanking region of
the VGAT gene, respectively, do not affect the expression
level of VGAT protein. Therefore, the VGAT-floxneo
A
-70 mV (Control)
-70 mV (CNQX + AP5)
-40 mV (Control)
-40 mV (STRY + Picrotoxin)
-40 mV (Control)
VGAT-/- Control
-70 mV (Control)
B
Figure 3 Electrophysiological characteristics of synaptic transmission in the VGAT
-/- spinal cord. (A) A representative whole-cell patch-
clamp recordings from control motoneurons (MNs) in a voltage clamp. In control motoneurons, spontaneous outward currents were observed
when the membrane potential was held at -40 mV (upper trace). These currents were blocked by bath application of strychnine (STRY, 0.5 μM)
and picrotoxin (50 μM) (middle trace). Inward currents persisted in the presence of these antagonists and became prominent when the
membrane potential was held at -70 mV. (B) In VGAT
-/- (VGAT-/-) MNs, no spontaneous outward currents were observed (upper trace). Inward
currents observed at -70 mV (middle trace) were blocked by CNQX (10 μM) and AP5 (50 μM). Vertical bars indicate 100 pA (A) and 50 pA (B).
Horizontal bars indicate 2 s (A, B).
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Figure 4 Histological analysis of VGAT
-/- mice. Histological analysis (hematoxylin and eosin staining) of trapezius muscle (A, B), sagittal
sections (C, D), liver (E, F) and lung (G, H) from E18.5 VGAT
-/- mice (B, D, F, H) and control mice (A, C, E, G). (A, B) The trapezius muscle (bounded
partly by white dashed lines) of VGAT
-/- mouse (B) was thinner than the control mouse (A). Scale bar: 200 μm. (C, D) The VGAT
-/- ribs (arrow in
D) in the lower part were depressed, and their position was inside compared to the control ribs (arrow in C). H, heart; L, liver. (E, F) Red blood
cell congestion was characteristic of VGAT
-/- liver, but not control liver. Scale bar: 200 μm. (G, H) The VGAT
-/- lung contained much less alveolar
space than the control lung. Scale bar: 500 μm.
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Page 7 of 13allele allowed for Cre-mediated conditional inactivation
of the VGAT gene, and mice carrying these alleles will be
useful in examining VGAT function at different develop-
mental stages and in distinct cell types.
Increase of overall GABA and glycine contents in VGAT
-/-
forebrains
We showed that both GABA and glycine contents were
increased in the VGAT
-/- forebrain, but not an excita-
tory neurotransmitter glutamate, which is transported
into synaptic vesicles by vesicular glutamate transpor-
ters. An increase in GABA content in VGAT
-/- mice is
similar to that in ACh contents in VAChT knockout
mice [16], but it is opposite of the decrease in monoa-
mine contents in vesicular monoamine transporter 2
knockout mice. In C. elegans, the mutational inactiva-
tion of VGAT also leads to an increase in GABA immu-
noreactivity in GABAergic neurons [24]. In VAChT
knockout mice the amount of the ACh-synthesizing
enzyme choline acetyltransferase (ChAT) is increased at
the mRNA and protein levels compared to their wild-
type littermates, suggesting that the change in ChAT
expression may be related to a compensatory mechan-
ism due to the lack of ACh release [16]. Conversely, the
amounts of the GABA-synthesizing enzymes GAD65
and GAD67 were not different in between the brains of
VGAT
-/- mice and their control littermates (Figure 2B).
Therefore, it is possible that the increased GABA in
VGAT
-/- brain was due to a reduction in their degrada-
tion. GABA and glycine are released from presynaptic
VGAT-/- GAD67-/-
Gut Gut
Liver Liver
WT
WT
Tongue
Tongue
Tongue
VGAT-/- GAD67-/-
B
A
Figure 5 Histological comparison of omphalocele and cleft palate between VGAT
-/- and GAD67
-/- mice. (A) Hematoxylin-eosin stained
coronal sections of the facial region of E18.5 wild-type (left panel), VGAT
-/- (middle panel) and GAD67
-/- (right panel) mice. Histological
examination revealed that the secondary palatal shelves (arrowhead) of VGAT
-/- mice were directed vertically down along the side of tongue in
contrast to the fused palate of wild-type mice. In the cleft palate of GAD67
-/- mice (right panel), palatal shelves failed to fuse but were elevated
horizontally unlike those in VGAT
-/- mice. (B) Hematoxylin-eosin stained coronal sections of the umbilical region of E18.5 wild-type (left panel),
VGAT
-/- (middle panel) and GAD67
-/- (right panel) embryos. The ventral body wall of the VGAT
-/- mice did not close and the gut protruded from
the peritoneal cavity. In contrast to VGAT
-/- mice, the ventral body wall of wild-type mice closed around the umbilicus, and the gut had already
returned to the peritoneal cavity. The omphalocele in GAD67
-/- mice was less severe than in VGAT
-/- mice because a large amount of gut was
observed at the umbilical level in VGAT
-/- mice compared to GAD67
-/- mice.
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Page 8 of 13neurons into the synaptic cleft and are retrieved in neu-
rons and glial cells by plasma membrane transporters
[25,26]. GABA and glycine taken up in glial cells are
further metabolized, but the GABA and glycine taken
up in neurons are directly recycled into synaptic vesicles
[27,28]. Because degradation systems for both GABA
and glycine are mainly localized to glial cells [27,29], the
transport into glial cells from the synaptic cleft is impor-
tant for their degradation. Because the synaptic release
of GABA and glycine was absent in VGAT
-/- mice, the
deletion of VGAT may result in little or no transport of
GABA and glycine into glial cells. GABA and glycine
then accumulate in the GABAergic and glycinergic neu-
rons, respectively, but they are not degraded in the glial
cells of VGAT
-/- mice.
Contribution of VGAT to motor function
In the embryonic spinal cord of rodents, synaptic trans-
mission to MNs mediated by GABA and glycine is pro-
minent from the early fetal period [30,31]. Our results
from the electrophysiological recordings of spinal cord
MNs indicate that the inhibitory synaptic transmission
was clearly absent in the VGAT knockout MNs, but
that the excitatory synaptic transmission was present.
Our results also suggest the absence of other functional
mechanisms that transport GABA and/or glycine into
synaptic vesicles in these synapses. VGAT
-/- fetuses at
E17.5-18.5 not only were completely immobile and stiff,
but also none of them responded to mechanical stimuli
by pinching the limb or the tail. Therefore, it is probable
that the lack of inhibitory transmission onto MNs in
VGAT
-/- fetuses resulted in defects in the spontaneous
and stimulus-induced movements in vivo despite the
presence of excitatory synaptic transmission.
In addition to the defect in motor movement, trape-
zius muscle displayed atrophy in VGAT
-/- mice.
Embryonic myogenesis progresses by the proliferation of
myoblasts and fusion of myotubes, but it requires sub-
stantial cell death [32]. Physical forces play a significant
role in the development and maintenance of skeletal
muscle [33]. In cultured myoblasts, chronic and cyclic
stretch results in an increase in cell death, including
apoptosis [34]. Therefore, a possible explanation for the
atrophy in VGAT
-/- trapezius muscle is that stretching
of the trapezius muscle due to the hunched posture
caused an increase in apoptosis during development.
Phenotypes of VGAT and GAD67 knockouts outside of
the brain
Ventral body wall closure abnormalities, such as ompha-
locele, are common human birth defects, but their
molecular and cellular bases are poorly understood [35].
T h em o u s ep r o v i d e sam o d e ls y s t e mt os t u d yt h e
genetic defects and environmental insults that can lead
to ventral body wall closure abnormalities [20]. In this
study, omphalocele was observed in VGAT
-/- and
GAD67
-/- mice, indicating that the lack of GABA signal-
ing was involved in its onset. Omphalocele has been
observed in K
+-Cl
--cotransporter 2 (KCC2) knockout
mice [36], and KCC2 is required for GABA- and/or gly-
cine-induced hyperpolarizing responses [37]. In the
KCC2 knockout mice, GABA and/or glycine signals
continue to act in an excitatory, but not an inhibitory,
manner. Therefore, the omphaloceles observed in both
VGAT
-/- mice and GAD67
-/- mice resulted from defects
in the inhibitory neurotransmission derived from the
hyperpolarizing response. A lack of inhibitory transmis-
sion in VGAT
-/- mice may lead to motor deficits, such
as a hunched posture. It is likely that the hunched pos-
ture resulted in increases in both intrathoracic and
intraabdominal pressures and this increased pressure
caused omphalocele.
Concerning the mechanism of onset of cleft palate,
studies using knockout mice have revealed associations
between cleft palate and mutation of genes related to
GABA signaling, such as GAD67 and GABRB3 [8,23,38].
B e c a u s et h el a c ko ft h eG A D 6 7g e n el e a d st oar e d u c -
tion in tongue movement [39], the sluggish tongue may
be an obstacle to development of the palatal shelves.
The cleft palate and omphalocele phenotypes were
more severe in VGAT
-/- mice than in GAD67
-/- mice.
Glycinergic transmission is present in embryonic spinal
cord and brainstem [40]. Hyperekplexia is a neuroge-
netic disorder caused mostly by mutations in the gene
encoding the a1 subunit of glycine receptor and is char-
acterized by an exaggerated startle response and neona-
tal hypertonia. In patients with hyperekplexia, the
recurrent abdominal muscle contraction from the exag-
gerated startle response can increase the abdominal
pressure and lead to omphalocele and inguinal hernia
[41,42]. These reports suggest that a defect in glyciner-
gic transmission is involved in the onset of omphalocele.
A small amount of GABA is synthesized by another
GAD isoform, GAD65, at the embryonic stage [8,43].
T h ed i f f e r e n c e si nt h es e v e r i t yb e t w e e nV G A T
-/- and
GAD67
-/- mice must be due to the presence of both gly-
cinergic and GAD65-produced GABAergic transmission
in GAD67
-/- fetuses, but not in VGAT
-/- fetuses.
Conclusion
In the present study, we established a VGAT knockout
mouse, with which we demonstrated that VGAT is fun-
damental for GABAergic and/or glycinergic transmis-
sion. We also showed that VGAT is important for fetal
growth and the development of muscle, liver and lung.
The VGAT knockout mice described here may provide
a useful tool for the study of specific functions of
VGAT-dependent GABAergic and/or glycinergic
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into several subtypes according to the expression of che-
mical markers, such as parvalbumin and somatostatin
[44,45]. Therefore, our floxed VGAT mice will be useful
for conditional knockout studies to further investigate
the role of VGAT in GABAergic neuronal subtypes.
Methods
Animals
All animal procedures were conducted in accordance with
the guiding principles of the NIH under the review and
approval of the Animal Care and Experimentation Com-
mittee, Gunma University, Showa Campus (Maebashi,
Japan). Every effort was made to minimize the number of
animals used and their suffering.
Construction of the Targeting Vector
Genomic BAC clones containing the mouse VGAT
(mVGAT) locus were purchased, and the regions cover-
ing the entire VGAT gene were subcloned [13]. A geno-
mic fragment spanning exons 1-3 of the mVGAT gene
was used for the targeting vector (Figure 1; targeting
vector). The HindIII (in the 5’-flanking region) - KpnI
(in the 3’-flanking region) fragment (7.5 kb) was sub-
cloned into pBluescript II KS(-), and the 5’-loxP site was
introduced into the XbaI site (in intron 1). The 5’-loxP
site was flanked by a KpnI site artificially introduced for
Southern blot analysis. The 7.5 kb fragment was used as
the 5’ homologous region containing the 5’-flanking
region, exons 1-3 and the 3’-flanking region. The frt-
flanked PGK-Neo cassette for positive selection of ES
clones and the 3’- l o x Ps i t ew e r ei n s e r t e di n t ot h eK p n I
site (in the 3’-flanking region). The KpnI-BstEII frag-
ment in the 3’-flanking region (3.5 kb) was added as the
3’ homologous region. An MC1-DT-ApA cassette for
negative selection [46] was ligated to the 3’ end of the
homologous region.
Creation of a VGAT knockout allele
The linearized targeting vector was introduced by elec-
troporation into ES cells (CCE) of 129/SvEv mouse ori-
gin, and G418-resistant colonies were screened by
Southern blot analysis using probes outside of the tar-
geting vector. KpnI-digested genomic DNA prepared
from ES cell colonies was hybridized with 5’ probes.
The correctly targeted ES clones were injected into
C57BL/6 blastocysts to produce germline chimeras. The
germline chimeras were mated with C57BL/6 mice to
establish the VGAT
floxneo/+ mouse line. VGAT
floxneo/+
mice were crossed with CAG-Cre mice [14] to excise
exons 2 and 3 (VGAT knockout allele), and VGAT
+/-
mice were obtained. We then intercrossed VGAT
+/-
mice to generate VGAT
-/- mice. When we performed
timed matings of the VGAT
+/- mice, the morning on
the day of vaginal plug detection was designated E0.5.
Genotypes of VGAT
+/+,V G A T
+/- and VGAT
-/- mice
were determined by PCR using the following oligonu-
cleotides: primer P1 (5’-AGTCTGATCCCGTGG-
CACTTCCAACTC-3’) corresponding to intron 1 of the
VGAT gene and primers P2 (5’-TCAGAGGCTTCT
TCCTAGGGCTGCTG-3’)a n dP 3( 5 ’-GACCTCCCC-
CATTGCATAGAATGGCAC-3’) corresponding to the
3’-flanking region of the VGAT gene. The primer set of
P2 and P3 amplified a 183-bp fragment specific for the
wild-type allele, and the primer set of P1 and P3 yielded
a 430-bp fragment specific for the knockout allele.
GAD67 knockout mice
We used homozygous GAD67-GFP (ℾneo) (GAD67
GFP/
GFP) mice as GAD67 knockout (GAD67
-/-) mice. The gen-
eration of the GAD67-GFP (ℾneo) mice and their geno-
typing by PCR were described previously [47,48]. In the
GAD67-GFP (ℾneo) mice, a cDNA encoding enhanced
green fluorescent protein (EGFP) followed by an SV40
polyadenylation signal was targeted to the locus encoding
GAD67 by homologous recombination, and the GAD67
gene was disrupted.
Western blotting and measurement of neurotransmitter
contents
For Western blotting, homogenates prepared from E18.5
mouse brain were separated by 7.5% SDS-polyacrylamide
gel electrophoresis, transferred to nitrocellulose mem-
brane (Whatman, Maidstone, UK), and probed with anti-
bodies specific for VGAT (1:1000) [49], GAD65/67
(1:1000) [50], synaptophysin (1:1000) (Synaptic Systems,
Goettingen, Germany), and b-actin (1:10000) (Abcam,
Cambridge, UK). After the membranes were washed with
Tris-HCl buffered saline containing 0.05% (w/v) Tween
20, the bound antibodies were visualized with horserad-
ish peroxidase-conjugated goat anti-mouse IgG or anti-
rabbit IgG (Jackson ImmunoResearch Laboratories, West
Grove, PA) using the ECL Western blotting detection
system (GE Healthcare, London, UK). Protein levels were
quantified using Light Capture and its quantification soft-
ware (ATTO, Tokyo, Japan). Expression levels were nor-
malized to b-actin or synaptophysin levels, and the values
are expressed as means ± SE. Statistical significance was
assessed using Student’s t-test.
GABA, glycine, and glutamate contents in the E18.5
mouse forebrain were measured according to previously
described method [21,47].
Electrophysiological recording in spinal cord
Embryos (E17.5-18.5) of control (VGAT
+/+;n=3 ,
VGAT
+/-;n=5 )a n dV G A T
-/- (n = 12) mice were
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Page 10 of 13decapitated and eviscerated, and the spinal cord was
removed by ventral laminectomy. The isolated spinal cord
was placed in a recording chamber perfused with oxyge-
nated Ringer’s solution (118.4 mM NaCl, 3 mM KCl, 2.52
mM CaCl2, 1.25 mM MgSO4, 25 mM NaHCO3, 1.18 mM
KH2PO4, and 11.1 mM D-glucose aerated with 5% CO2 in
O2) at room temperature. Recordings from MNs in the
isolated spinal cord were performed as described pre-
viously [17]. Briefly, visually guided whole-cell tight-seal
recording of MNs was performed with patch electrodes
pulled from thick walled borosilicate glass to a final resis-
tance of 5-8 MΩ. The electrode tips were filled with (in
mM) 138 K-gluconate, 10 HEPES, 1 CaCl2,5A T P - M g ,
and 0.3 GTP-Li. Intracellular signals were amplified with a
Multiclamp 700B amplifier (Molecular Devices, Union
City, CA), digitized at 5 kHz with the Digidata 1440A data
acquisition system (Molecular Devices) and saved on a
hard disk for off-line analysis. Electrical stimulations of
lumbar ventral roots (VRs) were performed using glass
suction electrodes. MNs were identified visually as cells
with large soma in the ventral horn and by observing the
antidromic firing activated by the electrical stimulation of
the adjacent VR. All drugs (CNQX, AP5, strychnine and
picrotoxin; Sigma-Aldrich, St. Louis, MO) were dissolved
in Ringer’s solution and bath-applied to the preparation.
Analysis was performed using pClamp 10 software (Mole-
cular Devices).
Histology
VGAT
-/-,V G A T
+/- and VGAT
+/+ mice at E18.5 were
investigated. Samples were fixed in 10% (vol/vol) formal-
dehyde, dehydrated with a graded series of ethanol solu-
tions, and embedded in paraffin. Three-micrometer
sections were prepared, subjected to paraffin removal by
immersion in xylene, rehydrated, and stained with
hematoxylin-eosin. VGAT
+/- and VGAT
+/+ mice were
mixed together and are referred to as control mice.
Additional material
Additional file 1: Supplementary Figure S1. VGAT expression levels in
VGAT mutant mice. (A, B) VGAT expression level was normal in adult
VGAT
floxneo/floxneo mice. Western blot of whole brain homogenates from
adult VGAT
+/+ (+/+) and VGAT
floxneo/floxneo (floxneo/floxneo) mice is shown
(A). VGAT expression level normalized to b-actin was not different between
VGAT
+/+ (+/+) and VGAT
floxneo/floxneo (floxneo/floxneo) mice (B). (C, D) VGAT
expression level was reduced by about half in adult VGAT
+/- mice. Western
blot of whole brain homogenates of adult VGAT
+/+ (+/+) and VGAT
+/- (+/-)
mice is shown (C). VGAT expression level normalized to synaptophysin was
significantly different between VGAT
+/+ (+/+) and VGAT
+/- (+/-) mice (D).
Significance was tested by Student’s t-test (*P < 0.05).
Acknowledgements
The authors thank Ms. Honma, Ms. Hara and Ms. Yamazaki for technical
assistance, and Ms. Shimoda and Ms. Owada for secretarial assistance. We
thank Drs. Iso and Kurabayashi for the experiments and helpful discussion.
We also thank the staff at the Institute of Experimental Animal Research,
Gunma University Graduate School of Medicine for technical help. This study
was supported by Grants-in-Aid for Scientific Research from the Ministry of
Education, Culture, Sports, Science and Technology (MEXT) of Japan, a grant
from the Co-operative Study Program of National Institute for Physiological
Sciences, Japan, Research for Promoting Technological Seeds, and Takeda
Science Foundation.
Author details
1Department of Genetic and Behavioral Neuroscience, Gunma University
Graduate School of Medicine, Maebashi 371-8511, Japan.
2The Graduate
University for Advanced Studies, Hayama, Kanagawa 240-0193, Japan.
3Japan
Science and Technology Agency, CREST, Tokyo 102-0075, Japan.
4Department of Pathology, Institute of Development, Aging and Cancer,
Tohoku University, Sendai 980-8575, Japan.
5Graduate School of
Comprehensive Human Science, University of Tsukuba, Tsukuba 305-8577,
Japan.
6Department of Physiology, Hamamatsu University School of
Medicine, Hamamatsu 431-3192, Japan.
7Department of Human Pathology,
Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan.
8Doshisha University Faculty of Life and Medical Sciences, Kyotanabe, Kyoto
610-0394, Japan.
9Department of Cellular Neurobiology, Graduate School of
Medicine, University of Tokyo, Tokyo 113-0033, Japan.
10Department of
Materials Science, Toyohashi University of Technology, Toyohashi 441-8580,
Japan.
11Department of Molecular Neurobiology and Pharmacology,
Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan.
12Division of Stem Cell Regulation Research, G6, Osaka University Graduate
School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
13Mitsubishi Kagaku Institute of Life Sciences, MITILS, 11 Minamiooya,
Machida, Tokyo, 194-8511, Japan.
14Obata Research Unit, RIKEN Brain Science
Institute, Wako 351-0198, Japan.
Authors’ contributions
Conceived and designed the experiments: KS, TK, HN, YN, MY, SK, AF, MF,
KN, KO, YY. Performed the experiments: KS, TK, HN, TF, RH, ST, SE, MU, KI, MF,
KN, KO, YY. Analyzed the data: KS, TK, HN, TF, RH, KI, AF, MF, KN, KO, YY.
Contributed new reagents/analytical tools: ST, MM, JM. Wrote the paper: KS,
TK, HN, AF, MF, KN, KO, YY. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 26 November 2010 Accepted: 30 December 2010
Published: 30 December 2010
References
1. Roberts E, Kuriyama K: Biochemical-physiological correlations in studies of
the gamma-aminobutyric acid system. Brain Res 1968, 8:1-35.
2. McIntire SL, Reimer RJ, Schuske K, Edwards RH, Jorgensen EM: Identification and
characterization of the vesicular GABA transporter. Nature 1997, 389:870-876.
3. Sagne C, El Mestikawy S, Isambert MF, Hamon M, Henry JP, Giros B,
Gasnier B: Cloning of a functional vesicular GABA and glycine transporter
by screening of genome databases. FEBS Lett 1997, 417:177-183.
4. Bu DF, Erlander MG, Hitz BC, Tillakaratne NJ, Kaufman DL, Wagner-
McPherson CB, Evans GA, Tobin AJ: Two human glutamate
decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a
single gene. Proc Natl Acad Sci USA 1992, 89:2115-2119.
5. Esclapez M, Tillakaratne NJ, Kaufman DL, Tobin AJ, Houser CR: Comparative
localization of two forms of glutamic acid decarboxylase and their
mRNAs in rat brain supports the concept of functional differences
between the forms. J Neurosci 1994, 14:1834-1855.
6. Stork O, Ji FY, Kaneko K, Stork S, Yoshinobu Y, Moriya T, Shibata S, Obata K:
Postnatal development of a GABA deficit and disturbance of neural
functions in mice lacking GAD65. Brain Res 2000, 865:45-58.
7. Kubo K, Nishikawa K, Ishizeki J, Hardy-Yamada M, Yanagawa Y, Saito S:
Thermal hyperalgesia via supraspinal mechanisms in mice lacking
glutamate decarboxylase 65. J Pharmacol Exp Ther 2009, 331:162-169.
8. Asada H, Kawamura Y, Maruyama K, Kume H, Ding RG, Kanbara N,
Kuzume H, Sanbo M, Yagi T, Obata K: Cleft palate and decreased brain
gamma-aminobutyric acid in mice lacking the 67-kDa isoform of
glutamic acid decarboxylase. Proc Natl Acad Sci USA 1997, 94:6496-6499.
Saito et al. Molecular Brain 2010, 3:40
http://www.molecularbrain.com/content/3/1/40
Page 11 of 139. Dumoulin A, Rostaing P, Bedet C, Lévi S, Isambert MF, Henry JP, Triller A,
Gasnier B: Presence of the vesicular inhibitory amino acid transporter in
GABAergic and glycinergic synaptic terminal boutons. J Cell Sci 1999,
112:811-823.
10. Wojcik SM, Katsurabayashi S, Guillemin I, Friauf E, Rosenmund C, Brose N,
Rhee JS: A shared vesicular carrier allows synaptic corelease of GABA
and glycine. Neuron 2006, 50:575-587.
11. Aubrey KR, Rossi FM, Ruivo R, Alboni S, Bellenchi GC, Le Goff A, Gasnier B,
Supplisson S: The transporters GlyT2 and VIAAT cooperate to determine
the vesicular glycinergic phenotype. J Neurosci 2007, 27:6273-6281.
12. Saito K, Nakamura K, Kakizaki T, Ebihara S, Uematsu M, Takamori S,
Yokoyama M, Konishi S, Mishina M, Miyazaki JI, Obata K, Yanagawa Y:
Generation and analysis of vesicular GABA transporter knockout mouse
[abstract]. Neurosci Res 2006, 55:S80.
13. Ebihara S, Obata K, Yanagawa Y: Mouse vesicular GABA transporter gene:
genomic organization, transcriptional regulation and chromosomal
localization. Brain Res Mol Brain Res 2003, 110:126-139.
14. Sakai K, Miyazaki J: A transgenic mouse line that retains Cre recombinase
activity in mature oocytes irrespective of the cre transgene transmission.
Biochem Biophys Res Commun 1997, 237:318-324.
15. Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW,
Wightman RM, Caron MG: Knockout of the vesicular monoamine
transporter 2 gene results in neonatal death and supersensitivity to
cocaine and amphetamine. Neuron 1997, 19:1285-1296.
16. de Castro BM, De Jaeger X, Martins-Silva C, Lima RD, Amaral E, Menezes C,
Lima P, Neves CM, Pires RG, Gould TW, Welch I, Kushmerick C,
Guatimosim C, Izquierdo I, Cammarota M, Rylett RJ, Gomez MV, Caron MG,
Oppenheim RW, Prado MA, Prado VF: The vesicular acetylcholine
transporter is required for neuromuscular development and function.
Mol Cell Biol 2009, 29:5238-5250.
17. Nishimaru H, Restrepo CE, Ryge J, Yanagawa Y, Kiehn O: Mammalian motor
neurons corelease glutamate and acetylcholine at central synapses. Proc
Natl Acad Sci USA 2005, 102:5245-5249.
18. Toribio RE, Brown HA, Novince CM, Marlow B, Hernon K, Lanigan LG,
Hildreth BE, Werbeck JL, Shu ST, Lorch G, Carlton M, Foley J, Boyaka P,
McCauley LK, Rosol TJ: The midregion, nuclear localization sequence, and
C terminus of PTHrP regulate skeletal development, hematopoiesis, and
survival in mice. FASEB J 2010, 24:1947-1957.
19. Yoda E, Hachisu K, Taketomi Y, Yoshida K, Nakamura M, Ikeda K, Taguchi R,
Nakatani Y, Kuwata H, Murakami M, Kudo I, Hara S: Mitochondrial
dysfunction and reduced prostaglandin synthesis in skeletal muscle of
Group VIB Ca2+-independent phospholipase A2gamma-deficient mice. J
Lipid Res 2010, 51:3003-3015.
20. Brewer S, Williams T: Finally, a sense of closure? Animal models of human
ventral body wall defects. Bioessays 2004, 26:1307-1321.
21. Fujii M, Arata A, Kanbara-Kume N, Saito K, Yanagawa Y, Obata K:
Respiratory activity in brainstem of fetal mice lacking glutamate
decarboxylase 65/67 and vesicular GABA transporter. Neuroscience 2007,
146:1044-1052.
22. Baertschi S, Zhuang L, Trueb B: Mice with a targeted disruption of the
Fgfrl1 gene die at birth due to alterations in the diaphragm. FEBS J 2007,
274:6241-6253.
23. Condie BG, Bain G, Gottlieb DI, Capecchi MR: Cleft palate in mice with a
targeted mutation in the gamma-aminobutyric acid-producing enzyme
glutamic acid decarboxylase 67. Proc Natl Acad Sci USA 1997,
94:11451-11455.
24. McIntire SL, Jorgensen E, Horvitz HR: Genes required for GABA function in
Caenorhabditis elegans. Nature 1993, 364:334-337.
25. Aragon C, Lopez-Corcuera B: Structure, function and regulation of glycine
neurotransporters. Eur J Pharmacol 2003, 479:249-262.
26. Conti F, Minelli A, Melone M: GABA transporters in the mammalian
cerebral cortex: localization, development and pathological implications.
Brain Res Brain Res Rev 2004, 45:196-212.
27. Cherubini E, Conti F: Generating diversity at GABAergic synapses. Trends
Neurosci 2001, 24:155-162.
28. Schousboe A: Role of astrocytes in the maintenance and modulation of
glutamatergic and GABAergic neurotransmission. Neurochem Res 2003,
28:347-352.
29. Sato K, Yoshida S, Fujiwara K, Tada K, Tohyama M: Glycine cleavage system
in astrocytes. Brain Res 1991, 567:64-70.
30. Nishimaru H, Iizuka M, Ozaki S, Kudo N: Spontaneous motoneuronal
activity mediated by glycine and GABA in the spinal cord of rat fetuses
in vitro. J Physiol 1996, 497:131-143.
31. Hanson MG, Landmesser LT: Characterization of the circuits that generate
spontaneous episodes of activity in the early embryonic mouse spinal
cord. J Neurosci 2003, 23:587-600.
32. Sandri M, Carraro U: Apoptosis of skeletal muscles during development
and disease. Int J Biochem Cell Biol 1999, 31:1373-1390.
33. Proske U, Morgan DL: Muscle damage from eccentric exercise:
mechanism, mechanical signs, adaptation and clinical applications. J
Physiol 2001, 537:333-345.
34. Liu J, Liu J, Mao J, Yuan X, Lin Z, Li Y: Caspase-3-mediated cyclic stretch-
induced myoblast apoptosis via a Fas/FasL-independent signaling
pathway during myogenesis. J Cell Biochem 2009, 107:834-844.
35. Williams T: Animal models of ventral body wall closure defects: a
personal perspective on gastroschisis. Am J Med Genet C Semin Med Genet
2008, 148C:186-191.
36. Hubner CA, Stein V, Hermans-Borgmeyer I, Meyer T, Ballanyi K, Jentsch TJ:
Disruption of KCC2 reveals an essential role of K-Cl cotransport already
in early synaptic inhibition. Neuron 2001, 30:515-524.
37. Delpire E: Cation-Chloride Cotransporters in Neuronal Communication.
News Physiol Sci 2000, 15:309-312.
38. Homanics GE, DeLorey TM, Firestone LL, Quinlan JJ, Handforth A,
Harrison NL, Krasowski MD, Rick CE, Korpi ER, Makela R, Brilliant MH,
Hagiwara N, Ferguson C, Snyder K, Olsen RW: Mice devoid of gamma-
aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate,
and hypersensitive behavior. Proc Natl Acad Sci USA 1997, 94:4143-4148.
39. Tsunekawa N, Arata A, Obata K: Development of spontaneous mouth/
tongue movement and related neural activity, and their repression in
fetal mice lacking glutamate decarboxylase 67. Eur J Neurosci 2005,
21:173-178.
40. Greer JJ, Funk GD: Perinatal development of respiratory motoneurons.
Respir Physiol Neurobiol 2005, 149:43-61.
41. Suhren O, Bruyn GW, Tuynman JA: Hyperexplexia - A Hereditary Startle
Syndrome. J Neurol Sci 1966, 3:577-605.
42. Zhou L, Chillag KL, Nigro MA: Hyperekplexia: a treatable neurogenetic
disease. Brain Dev 2002, 24:669-674.
43. Ji F, Kanbara N, Obata K: GABA and histogenesis in fetal and neonatal
mouse brain lacking both the isoforms of glutamic acid decarboxylase.
Neurosci Res 1999, 33:187-194.
44. Kawaguchi Y, Kondo S: Parvalbumin, somatostatin and cholecystokinin as
chemical markers for specific GABAergic interneuron types in the rat
frontal cortex. J Neurocytol 2002, 31:277-287.
45. Ascoli GA, Alonso-Nanclares L, Anderson SA, Barrionuevo G, Benavides-
Piccione R, Burkhalter A, Buzsáki G, Cauli B, Defelipe J, Fairén A,
Feldmeyer D, Fishell G, Fregnac Y, Freund TF, Gardner D, Gardner EP,
Goldberg JH, Helmstaedter M, Hestrin S, Karube F, Kisvárday ZF,
Lambolez B, Lewis DA, Marin O, Markram H, Muñoz A, Packer A,
Petersen CC, Rockland KS, Rossier J, Rudy B, Somogyi P, Staiger JF, Tamas G,
Thomson AM, Toledo-Rodriguez M, Wang Y, West DC, Yuste R: Petilla
terminology: nomenclature of features of GABAergic interneurons of the
cerebral cortex. Nat Rev Neurosci 2008, 9:557-568.
46. Yanagawa Y, Kobayashi T, Ohnishi M, Kobayashi T, Tamura S, Tsuzuki T,
Sanbo M, Yagi T, Tashiro F, Miyazaki J: Enrichment and efficient screening
of ES cells containing a targeted mutation: the use of DT-A gene with
the polyadenylation signal as a negative selection maker. Transgenic Res
1999, 8:215-221.
47. Tamamaki N, Yanagawa Y, Tomioka R, Miyazaki J, Obata K, Kaneko T: Green
fluorescent protein expression and colocalization with calretinin,
parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J
Comp Neurol 2003, 467:60-79.
48. Kaneko K, Tamamaki N, Owada H, Kakizaki T, Kume N, Totsuka M,
Yamamoto T, Yawo H, Yagi T, Obata K, Yanagawa Y: Noradrenergic
excitation of a subpopulation of GABAergic cells in the basolateral
amygdala via both activation of nonselective cationic conductance and
suppression of resting K+ conductance: a study using glutamate
decarboxylase 67-green fluorescent protein knock-in mice. Neuroscience
2008, 157:781-797.
49. Takamori S, Riedel D, Jahn R: Immunoisolation of GABA-specific synaptic
vesicles defines a functionally distinct subset of synaptic vesicles. J
Neurosci 2000, 20:4904-4911.
Saito et al. Molecular Brain 2010, 3:40
http://www.molecularbrain.com/content/3/1/40
Page 12 of 1350. Asada H, Kawamura Y, Maruyama K, Kume H, Ding R, Ji FY, Kanbara N,
Kuzume H, Sanbo M, Yagi T, Obata K: Mice lacking the 65 kDa isoform of
glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67
and GABA in their brains but are susceptible to seizures. Biochem Biophys
Res Commun 1996, 229:891-895.
doi:10.1186/1756-6606-3-40
Cite this article as: Saito et al.: The physiological roles of vesicular GABA
transporter during embryonic development: a study using knockout
mice. Molecular Brain 2010 3:40.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Saito et al. Molecular Brain 2010, 3:40
http://www.molecularbrain.com/content/3/1/40
Page 13 of 13